How many milliliters of plain normal saline (0.9% NaCl) are typically added to reconstitute 100 units of Allergan Botox (onabotulinumtoxinA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Botox (Allergan) Reconstitution

— Use 2.0 mL of preservative‑free 0.9% normal saline to reconstitute a 100‑Unit vial of Allergan Botox (onabotulinumtoxinA). 1

  • Rationale and safety:

    • Preservative‑free 0.9% NaCl is the standard diluent to minimize contamination and adverse events that could affect morbidity and quality of life. 1
    • Discard if >4 hours after reconstitution; refrigerate until use. This reduces infection risk and toxin degradation, preserving efficacy. 1
  • Practical concentration from 2.0 mL:

    • 100 U/2.0 mL = 5 U per 0.1 mL.
  • Common pitfalls to avoid:

    • Do not use bacteriostatic saline (benzyl alcohol) due to potential toxin denaturation and safety concerns. Use preservative‑free saline only. 1
    • Avoid excessive dilution that increases spread and off‑target effects; higher volumes can increase diffusion and lower target localization, which may worsen functional outcomes. 2
    • Be vigilant for rare hypersensitivity reactions; select highly purified products and document prior reactions. Though rare, systemic reactions can impact morbidity. 3
  • If a different working concentration is required (e.g., facial aesthetics micro‑aliquots), keep total volume as low as feasible to limit diffusion; smaller per‑site volumes reduce mechanical spread. 2

References

Research

Proper dose, preparation, and storage of botulinum neurotoxin serotype A.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.